iRhythm to Acquire VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care
iRhythm Holdings has agreed to acquire privately held VitalConnect for approximately $287.5 million to expand its cardiac monitoring platform across ambulatory, inpatient, and hospital-to-home care settings. The deal combines iRhythm’s existing Zio service with VitalConnect’s mobile cardiac telemetry and multi-vitals monitoring capabilities, broadening the company's addressable market and patient care pathways.
Key figures
- Deal Value Usd
- 287500000
- Cash consideration
- $237.5 million
- Stock consideration
- $50 million
- Working capital limit
- $30 million
- Adjusted ebitda margin target 2027
- 15%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.